BioMarin Pharmaceutical Inc (BMRN): R&D Expense
$921.93M
Year ended 2025-12-31
$987.64M
Trailing 12 months to 2026-06-30
+12.4%
3-year compound annual growth
+8.0%
5-year compound annual growth
+3.8%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $921.93M | +23.4% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $747.18M | +0.1% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $746.77M | +15.0% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $649.61M | +3.3% | 2025-02-24, From 2022-01-01 |
| 2021-12-31 | $628.79M | +0.1% | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | $628.12M | -12.2% | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | $715.01M | +2.7% | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | $696.33M | +14.0% | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | $610.75M | -7.7% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $661.90M | +4.3% | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $634.81M | +37.5% | 2018-02-26, From 2015-01-01 |
| 2014-12-31 | $461.54M | +30.1% | 2017-02-27, From 2014-01-01 |
| 2013-12-31 | $354.78M | +17.4% | 2016-02-29, From 2013-01-01 |
| 2012-12-31 | $302.22M | +41.0% | 2015-03-02, From 2012-01-01 |
| 2011-12-31 | $214.37M | +45.5% | 2014-02-26, From 2011-01-01 |
| 2010-12-31 | $147.31M | +28.0% | 2013-02-26, From 2010-01-01 |
| 2009-12-31 | $115.12M | +23.4% | 2012-02-22, From 2009-01-01 |
| 2008-12-31 | $93.29M | n/a | 2011-02-24, From 2008-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $921.93M | +23.4% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $550.00M | +14.3% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $186.18M | -2.4% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $1.32B | +17.2% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $95.40M | -15.0% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $782.74M | -11.5% |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $452.00M | n/m |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $368.00M | +7.0% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $1.52B | +89.2% |
Compare BMRN, UTHR, AMRX, ALNY side by side · Screen every company in Pharmaceutical Preparations ↗